The 4G-allele of the PAI-1 gene is not consistently associated with a higher prevalence of coronary stenosis [4]

Journal of Thrombosis and Haemostasis

Volumn 2, Issue 9, 2004, Pages 1668-1670

  Ter Bogt, N C W ^a   Hoekstra, T ^a,b   Roest, M ^c   Van De Vijver, L P L ^d   Verhoef, Petra ^a,d  

^a WAGENINGEN UNIVERSITY   (Netherlands)

^b TOP INSTITUTE FOOD AND NUTRITION   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d TNO   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLASMINOGEN ACTIVATOR INHIBITOR 1; TRIACYLGLYCEROL;

ALLELE; BASE PAIRING; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; DISEASE ASSOCIATION; DNA POLYMORPHISM; FAMILY HISTORY; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC TRANSCRIPTION; GENOTYPE; HIGH RISK POPULATION; HUMAN; LETTER; MAJOR CLINICAL STUDY; PREVALENCE; PRIORITY JOURNAL; PROMOTER REGION;

ALLELES; CASE-CONTROL STUDIES; CORONARY STENOSIS; GENE FREQUENCY; HUMANS; PLASMINOGEN ACTIVATOR INHIBITOR 1; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 13244249554     PISSN: 15387933     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2004.00864.x     Document Type: Letter

References (12)

1. Hoekstra T, Geleijnse JM, Schouten EG, Kluft C. Plasminogen activator inhibitor-type 1 in plasma; its determinants and relation with cardiovascular risk. Thromb Haemost 2004; 91: 861-72.
2. Boekholdt SM, Bijsterveld NR, Moons AHM, Levi M, Büller HR, Peters RJG. Genetic variation in coagulation and fibrinolytic proteins and their relation with acute myocardial infarction. Circulation 2001; 104: 3063-8.
3. Iacoviello L, Burzotta F, Di Castelnuovo A, Zito F, Marchioli R, Donati MB. The 4G/5G polymorphism of PAI-1 promoter gene and the risk of myocardial infarction: a meta-analysis. Thromb Haemost 1998; 80: 1029-30.
4. Gardemann A, Lohre J, Katz N, Tillmanns H, Hehrlein FW, Haberbosch W. The 4G4G genotype of the plasminogen activator inhibitor 4G/5G gene polymorphism is associated with coronary atherosclerosis in patients at high risk for this disease. Thromb Haemost 1999; 82 1121-6.
5. van de Vijver LPL, Kardinaal AFM, van Duyvenvoorde W, Kruijssen DACM, Grobbee DE, vanPoppel G, Princen HMG. LDL oxidation and extent of coronary atherosclerosis. Arterioscler Thromb Vasc Biol 1998; 18: 193-9.
6. Verhoef P, Kok FJ, Kruyssen DACM, Schouten EG, Witteman JCM, Grobbee DE, Ueland PM, Refsum H. Plasma total homocysteine, B vitamins, and risk of coronary atherosclerosis. Arterioscler Thromb Vasc Biol 1997; 17: 989-95.
7. van Poppel G, van de Vijver LPL, Kosmeyer-Schuil T, Johanns ESD, Kardinaal AFM, vandeBovenkamp P, Kruyssen DACM, Kok FJ. Plasma oxysterols and angiographically determined coronary atherosclerosis: a case-control study. Biomarkers 1997; 2: 373-8.
8. Humphries SE, Green FR, Temple A, Dawson S, Henney A, Kelleher CH, Wilkes H, Meade TW, Wiman B, Hamsten A. Genetic factors determining thrombosis and fibrinolysis. Ann Epidemiol 1992; 2 371-85.
9. Roest M, van der Schouw YT, Banga JD, Tempelman MJ, de-Groot PG, Sixma JJ, Grobbee DE. Plasminogen activator inhibitor 4G polymorphism is associated with decreased risk of cerebrovascular mortality in older women. Circulation 2000; 101: 67-70.
10. Margaglione M, Grandone E, Cappucci G, Colaizzo D, Giuliani N, Vecchione G, dAddedda M, Di Minno G. An alternative method for PAI-1 promoter polymorphism (4G/5G) typing. Thromb Haemost 1997; 77 605-6.
11. Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation 1998; 97: 1837-47.
12. Doggen CJM, Bertina RM, Manger Cats V, Reitsma PH, Rosendaal FR. The 4G/5G polymorphism in the plasminogen activator inhibitor-1 gene is not associated with myocardial infarction. Thromb Haemost 1999; 82: 115-20.